SB1553 - 104th General Assembly

XYLAZINE-SCHED III-PENALTIES
Last Action
4/11/2025 - Senate: Rule 3-9(a) / Re-referred to Assignments
Senate Sponsors
Sen. Patrick J. Joyce
Statutes Amended In Order of Appearance
720 ILCS 570/208from Ch. 56 1/2, par. 1208
720 ILCS 570/309.1 new
720 ILCS 570/401from Ch. 56 1/2, par. 1401
Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides for penalties for the knowing manufacture or delivery, or possession with intent to manufacture or deliver xylazine. Provides that, notwithstanding the scheduling of xylazine as a Schedule III controlled substance, the prohibition on delivery or possession with intent to deliver xylazine does not apply to licensed veterinarians who lawfully prescribe, dispense, administer, acquire, or use any controlled substance, including xylazine, while acting in the course of their professional practice, in good faith, and in accordance with generally accepted medical standards.
Actions
Date Chamber Action
2/04/2025 Senate Filed with Secretary by Sen. Patrick J. Joyce
2/04/2025 Senate First Reading
2/04/2025 Senate Referred to Assignments
2/11/2025 Senate Assigned to Criminal Law
2/19/2025 Senate To Criminal Law Clear Compliance
3/21/2025 Senate Rule 2-10 Committee Deadline Established As April 4, 2025
4/04/2025 Senate Rule 2-10 Committee Deadline Established As April 11, 2025
4/11/2025 Senate Rule 3-9(a) / Re-referred to Assignments